Gabelli Funds’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Hold |
13,500
| – | – | ﹤0.01% | 1168 |
|
|
2025
Q1 | $95K | Hold |
13,500
| – | – | ﹤0.01% | 1042 |
|
|
2024
Q4 | $100K | Sell |
13,500
-4,500
| -25% | -$33.4K | ﹤0.01% | 1041 |
|
|
2024
Q3 | $88.7K | Sell |
18,000
-1,300
| -7% | -$6.41K | ﹤0.01% | 1038 |
|
|
2024
Q2 | $99K | Buy |
19,300
+300
| +2% | +$1.54K | ﹤0.01% | 1024 |
|
|
2024
Q1 | $101K | Buy |
19,000
+700
| +4% | +$3.72K | ﹤0.01% | 1027 |
|
|
2023
Q4 | $113K | Buy |
18,300
+1,700
| +10% | +$10.5K | ﹤0.01% | 1027 |
|
|
2023
Q3 | $125K | Hold |
16,600
| – | – | ﹤0.01% | 1037 |
|
|
2023
Q2 | $161K | Sell |
16,600
-400
| -2% | -$3.87K | ﹤0.01% | 1028 |
|
|
2023
Q1 | $64.2K | Sell |
17,000
-800
| -4% | -$3.02K | ﹤0.01% | 1077 |
|
|
2022
Q4 | $115K | Buy |
17,800
+300
| +2% | +$1.94K | ﹤0.01% | 1099 |
|
|
2022
Q3 | $156K | Hold |
17,500
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q2 | $174K | Buy |
17,500
+4,000
| +30% | +$39.8K | ﹤0.01% | 1200 |
|
|
2022
Q1 | $156K | Hold |
13,500
| – | – | ﹤0.01% | 1265 |
|
|
2021
Q4 | $150K | Sell |
13,500
-11,000
| -45% | -$122K | ﹤0.01% | 1283 |
|
|
2021
Q3 | $226K | Sell |
24,500
-14,500
| -37% | -$134K | ﹤0.01% | 1235 |
|
|
2021
Q2 | $439K | Buy |
39,000
+10,000
| +34% | +$113K | ﹤0.01% | 1093 |
|
|
2021
Q1 | $307K | Buy |
29,000
+6,000
| +26% | +$63.5K | ﹤0.01% | 1137 |
|
|
2020
Q4 | $250K | Buy |
+23,000
| New | +$250K | ﹤0.01% | 1102 |
|